Avadel Pharmaceuticals' Lumryz competes with Xyrem but faces major hurdles. Read why AVDL stock is risky, despite recent legal victories and FDA approval.
The Dow Jones Industrial Average advanced on Friday as the major U.S. averages headed for weekly gains. The blue-chip Dow gained 358 points, or 0.8%. The S&P 500 added 0.3%. The technology-heavy ...
Mark Levin and Dr. Arnn bring their knowledge and wisdom to bear in a candid conversation between lifelong friends on today’s latest news events. They will touch on the points of crisis in America, ...
Jay Clayton is a familiar face on Wall Street. The veteran corporate lawyer chaired the Securities and Exchange Commission under the first Trump administration, and now he is poised to return as U.S.
This includes British lawyer Simone White, Holly Bowles and Bianca Jones from Australia ... Methanol poisoning is suspected to have killed six people in Laos (Picture: Alamy Stock Photo) Once ...